Talk:Drospirenone

message: I have tried to make this easier to understand for an educated but non-physician audience, since not everyone knows what a VTE is, for example.
I disagree with the comments below about the Yasmin Survivors Forum being a "scare forum".  There are many online forums for patients and consumers to share information about risks, and the risks expressed are consistent with the FDA label but not everyone can understand an FDA label (and of course, nobody reads them because the writing is so small and the wording so technical.)
Universitydoc (talk) 22:07, 20 October 2012 (UTC)
thread_title:  General Comments 

message: In response to the comments below, I added key information about the research, including the major new study that was not yet published when the comments below were made (and when the article was previously edited).  It is now clear that the increase in VTEs is statistically significant in the vast majority of studies, when length of use and other potentially confounding variables are statistically controlled.  However, young women who are on for a shorter period of time have a somewhat greater risk.
Only 2 published studies don't show an increased risk, and both were funded by the company making Yasmin, and used some interesting data manipulations that independent researchers believe are not scientifically justified.  A recent article also defended those studies, but that article was also written by authors with substantial financial ties to Bayer.  While financial conflicts of interest don't necessarily negate a resaercher's findings, one has to consider potential bias when their results differ from all the studies conducted by independent researchers (all of which show significant risks).
Universitydoc (talk) 21:58, 20 October 2012 (UTC)
thread_title:  Adverse Reactions 

message: I've appended a section summarizing the current claims and litigation against Bayer regarding their marketing of Yaz.  While there are plenty of sources for reference, I just cited a couple of the more prominent press releases.  It wouldn't hurt for someone who has more experience with citations to make adjustments (ie. I'm not sure if the Reuters press release pages are permanent, so that may have to be changed).
I'm also going to redirect Yaz and Yasmin (I dunno about Yasminelle) to this page, as this drug is sufficiently well-known by those names (being the brand names it's marketed under).-K10wnsta (talk) 22:54, 30 October 2009 (UTC)
replies: text: Previous comment signed date incorrectly. Actually from October 2017. PriceDL (talk) 13:23, 31 December 2017 (UTC)
thread_title:  Litigation 

message: This article contains good information but it is very technical.  Millions of women use drospirenone so it would be good if this article didn't sound like a medical school textbook.  We should include good data, but also make it understandable to students and college educated consumers without making it sound like a sales pitch.  — Preceding unsigned comment added by 96.231.228.7 (talk) 17:35, 18 October 2012 (UTC)
thread_title:  Let's make this less like a text for doctors and more intelligible to a wider audience 

message: Hello fellow Wikipedians,
I have just modified  on Drospirenone. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
*Added archive https://web.archive.org/web/20050901154443/http://www.yasmin-us.com:80/ to http://www.yasmin-us.com/
When you have finished reviewing my changes, please set the checked parameter below to true or failed to let others know (documentation at ).
Cheers.—InternetArchiveBot (Report bug) 03:21, 17 December 2016 (UTC)
thread_title:  External links modified 

message: Would like to expand on this section and include how the chemistry relates to its mechanism of action, side effects and toxicity.
-trmor24  (talk) 21:00, 17 October 2017 (UTC)
replies: text: Previous comment signed date incorrectly. Actually from October 2017. PriceDL (talk) 13:22, 31 December 2017 (UTC)
replies: text:  Altered to avoid problems with Reports bot. PriceDL (talk) 13:25, 31 December 2017 (UTC)
thread_title:  Chemistry 

message: Comments on edits made November 1st: 
Does the draft submission reflect a neutral point of view? If not, specify… I think the draft submission indeed reflects a neutral point of view. The group did a good job stating only facts and avoiding opinion or unjustified statements. Drospirenone has been the topic of litigation and is known to cause clots, and therefore invites more controversy than other oral contraceptives. However, Group 6 does a good job avoiding biased claims and speculation and states only facts verified by the literature and other accessible secondary sources. Engiesalama (talk) 06:42, 7 November 2017 (UTC)
thread_title:  Comments 

message: The recent editions, which added on to the “Medical Uses” section, as well as the “Formulations” and “Litigation” sections all contain appropriate sources that are cited in the references. If not leading to the appropriate article on a website, they link to online PDFs where the information is found. One particular section in which there is no citation is under the “Forumlations” section, for Yasmin/Jamine/Yarina. There is no citation for its indication, which is for prevention of pregnancy for women who desire oral contraceptives.  — Preceding unsigned comment added by JMoises (talk • contribs) 07:36, 7 November 2017 (UTC)
thread_title:  Cited Secondary Sources 

message: There is no evidence of plagiarism or copyright violation found within the article.  — Preceding unsigned comment added by 2602:302:D118:9DA0:8C6D:2490:A377:5878 (talk) 19:32, 7 November 2017 (UTC)
thread_title:  Copyright & Plagiarism